Display options
Cite
Ost'ádal B, Ost'ádalová I, Skárka L, et al. Ischemic injury of the developing heart. Exp Clin Cardiol. 2002;7(2):93-8
Ost'ádal, B., Ost'ádalová, I., Skárka, L., Kolár, F., & Kopecký, J. (2002). Ischemic injury of the developing heart. Experimental and clinical cardiology, 7(2), 93-8.
Ost'ádal, Bohuslav, et al. "Ischemic injury of the developing heart." Experimental and clinical cardiology vol. 7,2 (2002): 93-8.
Ost'ádal B, Ost'ádalová I, Skárka L, Kolár F, Kopecký J. Ischemic injury of the developing heart. Exp Clin Cardiol. 2002;7(2):93-8. PMID: 19649230; PMCID: PMC2719176.
Copy Download .nbib Format: NLM
Share it on

Exp Clin Cardiol. 2002;7(2):93-8.

Ischemic injury of the developing heart.

Experimental and clinical cardiology

Bohuslav Ost'ádal, Ivana Ost'ádalová, L Skárka, F Kolár, Jan Kopecký

Affiliations

  1. Institute of Physiology, Academy of Sciences, Centre for Experimental Cardiovascular Research, and.

PMID: 19649230 PMCID: PMC2719176

Abstract

CARDIAC TOLERANCE TO ISCHEMIA CHANGES SIGNIFICANTLY DURING ONTOGENETIC DEVELOPMENT: the immature heart appears to be more resistant to ischemic injury than the adult myocardium. The mechanisms of the higher tolerance of the developing heart have not yet been satisfactorily clarified; age-dependent changes in energy metabolism have to be taken into consideration. Marked ontogenetic changes are displayed by the mitochondrial membrane potential (MMP): in newborn rats a single population of mitochondria with a relatively high MMP was observed but, with increasing age, the second population with a lower MMP appeared. Adaptation to chronic hypoxia and ischemic preconditioning failed to improve ischemic tolerance of the rat heart on the first postnatal day; the cardioprotective effect only developed at the end of the first postnatal week. Decreasing tolerance of the neonatal heart to ischemia is thus counteracted by the development of endogenous protection. It seems likely that both mitochondrial K(ATP) channels and nitric oxide may be involved in the protective mechanisms of adaptation to chronic hypoxia but not to that of ischemic preconditioning, at least in neonatal rats. Basic knowledge of the possible improvements of immature heart tolerance to ischemia may contribute to the design of therapeutic strategies for both pediatric cardiology and cardiac surgery.

Keywords: Cardiac protection; Developing heart; Tolerance to ischemia

References

  1. Circulation. 1986 Nov;74(5):1124-36 - PubMed
  2. J Mol Cell Cardiol. 1999 Oct;31(10):1821-31 - PubMed
  3. Physiol Rev. 1999 Jul;79(3):635-59 - PubMed
  4. Basic Res Cardiol. 1990 Sep-Oct;85(5):429-34 - PubMed
  5. J Cell Biol. 1970 Feb;44(2):354-60 - PubMed
  6. J Thorac Cardiovasc Surg. 1990 Dec;100(6):888-95 - PubMed
  7. Circulation. 1999 Mar 9;99(9):1249-54 - PubMed
  8. Cardiovasc Res. 2000 Apr;46(1):126-38 - PubMed
  9. J Thorac Cardiovasc Surg. 1990 Feb;99(2):280-7 - PubMed
  10. J Mol Cell Cardiol. 1998 Apr;30(4):857-65 - PubMed
  11. Circulation. 2001 Apr 17;103(15):1984-91 - PubMed
  12. Circ Res. 1991 Mar;68(3):662-73 - PubMed
  13. Basic Res Cardiol. 1999 Jun;94(3):188-98 - PubMed
  14. Eur J Biochem. 1995 May 15;230(1):235-41 - PubMed
  15. Mol Cell Biochem. 1998 Feb;179(1-2):21-6 - PubMed
  16. Cardiovasc Res. 1992 May;26(5):487-95 - PubMed
  17. Am J Physiol Heart Circ Physiol. 2001 Sep;281(3):H1295-303 - PubMed
  18. Biol Neonat. 1968;12(1):54-64 - PubMed
  19. J Mol Cell Cardiol. 1998 Mar;30(3):685-97 - PubMed
  20. Basic Res Cardiol. 2002 Mar;97(2):161-7 - PubMed
  21. Physiol Res. 2001;50(3):237-45 - PubMed
  22. Cardioscience. 1993 Jun;4(2):85-92 - PubMed
  23. Mol Cell Biochem. 1998 Jul;184(1-2):379-91 - PubMed
  24. Cardiovasc Res. 1994 Mar;28(3):312-9 - PubMed
  25. Pediatr Res. 2002 Oct;52(4):561-7 - PubMed
  26. J Physiol. 2000 Nov 15;529 Pt 1:37-47 - PubMed
  27. Circ Res. 1988 Oct;63(4):779-87 - PubMed
  28. Circ Res. 1980 Apr;46(4):503-12 - PubMed
  29. Circulation. 1998 Nov 10;98(19 Suppl):II206-13 - PubMed
  30. Pediatr Cardiol. 1986;7(1):25-9 - PubMed
  31. Circ Res. 2000 Nov 10;87(10):915-21 - PubMed
  32. Fed Proc. 1966 Jul-Aug;25(4):1243-6 - PubMed
  33. Can J Physiol Pharmacol. 1996 Jan;74(1):23-31 - PubMed
  34. Z Anat Entwicklungsgesch. 1971;133(3):288-304 - PubMed
  35. J Mol Cell Cardiol. 2001 Feb;33(2):331-41 - PubMed
  36. Mol Cell Biochem. 1994 Apr-May;133-134:277-86 - PubMed
  37. Mol Cell Biochem. 1998 Jan;178(1-2):87-94 - PubMed
  38. Physiol Res. 1995;44(1):45-51 - PubMed
  39. Am J Physiol. 1995 Mar;268(3 Pt 2):H1165-73 - PubMed
  40. Circ Res. 1979 Feb;44(2):250-62 - PubMed
  41. Eur J Biochem. 1996 Nov 1;241(3):895-900 - PubMed
  42. Int J Biochem. 1985;17(11):1163-9 - PubMed
  43. Mol Aspects Med. 1999 Jun;20(3):139-84 - PubMed

Publication Types